 Manufacturer: NovoNordisk Pharmaceuticals
Generic Name: Coagulation Factor VIIa (Recombinant), rFVIIa Room Temperature Stable
Indications: NovoSeven RT is indicated for:
-
treatment of bleeding episodes in hemophilia A or B with inhibitors and in acquired hemophilia
-
prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors and in acquired hemophilia
-
treatment of bleeding episodes in congenital FVII deficiency
-
prevention of bleeding in surgical intervenitons or invasive procedures in congential FVII deficiency
NovoSeven® RT Product Insert
Provider Billing Guide
How Supplied: 1.0mg vial, 2.0mg vial, 5.0mg vial
Available Sizes |
NDC Numbers |
NovoSeven® RT 1.0mg |
00169-7010-01 |
NovoSeven® RT 2.0mg |
00169-7020-01 |
NovoSeven® RT 5.0mg |
00169-7050-01 |
http://www.novosevenrt.com/
|
